These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35047505)

  • 1. SCG2 is a Prognostic Biomarker Associated With Immune Infiltration and Macrophage Polarization in Colorectal Cancer.
    Wang H; Yin J; Hong Y; Ren A; Wang H; Li M; Zhao Q; Jiang C; Liu L
    Front Cell Dev Biol; 2021; 9():795133. PubMed ID: 35047505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoting effect and immunologic role of secretogranin II on bladder cancer progression via regulating MAPK and NF-κB pathways.
    Zhou J; Dong C; Tan J; Wang G; Li Z; Li S; He Z
    Apoptosis; 2024 Feb; 29(1-2):121-141. PubMed ID: 37848672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia-inducible factor-1α in colorectal cancer.
    Fang C; Dai L; Wang C; Fan C; Yu Y; Yang L; Deng H; Zhou Z
    Mol Oncol; 2021 Dec; 15(12):3513-3526. PubMed ID: 34160138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High expression of secretogranin II increases oxaliplatin resistance of colorectal cancer cells].
    Deng J; Pan T; Zhou G; Gao Y; Peng W; Wei W; Lü C
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1657-1664. PubMed ID: 37933640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer.
    Weng S; Liu Z; Ren X; Xu H; Ge X; Ren Y; Zhang Y; Dang Q; Liu L; Guo C; Beatson R; Deng J; Han X
    Front Immunol; 2022; 13():873871. PubMed ID: 35844556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer.
    Ma Y; Zhan L; Yang J; Zhang J
    Front Pharmacol; 2022; 13():984555. PubMed ID: 36438826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of Tumor Microenvironment Components Identifies Five Stroma-Related Genes with Prognostic Implications in Colorectal Cancer.
    Liu JW; Yu F; Tan YF; Huo JP; Liu Z; Wang XJ; Li JM
    Cancer Biother Radiopharm; 2022 Dec; 37(10):882-892. PubMed ID: 33085921
    [No Abstract]   [Full Text] [Related]  

  • 8. NAV3 Is a Novel Prognostic Biomarker Affecting the Immune Status of the Tumor Microenvironment in Colorectal Cancer.
    Li M; Wang Z; Dong S; Xu Y
    J Immunol Res; 2022; 2022():8337048. PubMed ID: 35812247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts.
    Wang H; Li Z; Ou S; Song Y; Luo K; Guan Z; Zhao L; Huang R; Yu S
    Front Mol Biosci; 2022; 9():884839. PubMed ID: 35836930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 12. Weighted Gene Co-expression Network Analysis Identifies CALD1 as a Biomarker Related to M2 Macrophages Infiltration in Stage III and IV Mismatch Repair-Proficient Colorectal Carcinoma.
    Zheng H; Bai Y; Wang J; Chen S; Zhang J; Zhu J; Liu Y; Wang X
    Front Mol Biosci; 2021; 8():649363. PubMed ID: 33996905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
    Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
    J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD163 as a Potential Biomarker in Colorectal Cancer for Tumor Microenvironment and Cancer Prognosis: A Swedish Study from Tissue Microarrays to Big Data Analyses.
    Ma S; Zhao Y; Liu X; Sun Zhang A; Zhang H; Hu G; Sun XF
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
    Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-Specific Protease 52 as a Prognostic Biomarker Correlates with Tumor Microenvironment and Therapy Response in Colorectal Cancer.
    Zhou J; Nie H; Yang X; Wang F; Yu P; Yu Y; Ning Y; Lai J; Wang H; Zhao Q; Xu F
    Oncology; 2024 Jul; ():1-15. PubMed ID: 39047691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of LAGE3 correlates with prognosis and immune infiltrates in colorectal cancer: A bioinformatic analysis.
    Dong X; Lv S; Zhang X; Hao R
    Int Immunopharmacol; 2020 Aug; 85():106599. PubMed ID: 32438075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
    Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
    Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FABP6 Expression Correlates with Immune Infiltration and Immunogenicity in Colorectal Cancer Cells.
    Lian W; Wang Z; Ma Y; Tong Y; Zhang X; Jin H; Zhao S; Yu R; Ju S; Zhang X; Guo X; Huang T; Ding X; Peng M
    J Immunol Res; 2022; 2022():3129765. PubMed ID: 36033394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.